title: An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.
abstract: To elucidate the role of catecholamines in attention deficit disorder, the authors conducted an open 8-week trial of L-tyrosine in 12 adults with attention deficit disorder, residual type. Eight showed marked to moderate clinical response in 2 weeks; at 6 weeks these eight developed tolerance, suggesting that L-tyrosine is not useful in attention deficit disorder, residual type.
authors.forename: F W
authors.initials: FW
authors.lastname: Reimherr
authors.forename: P H
authors.initials: PH
authors.lastname: Wender
authors.forename: D R
authors.initials: DR
authors.lastname: Wood
authors.forename: M
authors.initials: M
authors.lastname: Ward
mesh_terms: D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010649:Phenylalanine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D014443:Tyrosine / Q000627:therapeutic use*
chemical_list: D014443:Tyrosine; D007980:Levodopa; D010649:Phenylalanine